Adagene Presents Results Reinforcing Best-in-Class Profile of ADG126
- Interim results in MSS CRC suggest that SAFEbody precision masking technology enables a new standard for anti-CTLA-4 therapy at higher, more frequent and repeat doses by overcoming longtime...